ShareHope Medicine Co Ltd Capital Reinvestment Ratio
ShareHope Medicine Co Ltd capital reinvestment ratio. ShareHope Medicine Co Ltd (8403) has a Capital Reinvestment Ratio of 0.35x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$113.37 Million) in capital expenditures (NT$39.14 Million). Check ShareHope Medicine Co Ltd (8403) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ShareHope Medicine Co Ltd (2017–2025)
Capital reinvestment ratio of ShareHope Medicine Co Ltd from 2017 to 2025. This chart tracks ShareHope Medicine Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore how fast is ShareHope Medicine Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
ShareHope Medicine Co Ltd Capital Reinvestment Ratio by Year (2017–2025)
ShareHope Medicine Co Ltd capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see ShareHope Medicine Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | NT$364.12 Million | NT$131.81 Million | ▲ +3.8% |
| 2024 | 0.35x | NT$266.68 Million | NT$93.02 Million | ▼ -67.6% |
| 2023 | 1.08x | NT$257.13 Million | NT$277.20 Million | ▼ -46.1% |
| 2022 | 2.00x | NT$642.47 Million | NT$1.28 Billion | ▲ +372.7% |
| 2021 | 0.42x | NT$360.10 Million | NT$152.26 Million | ▼ -16.6% |
| 2020 | 0.51x | NT$717.74 Million | NT$364.00 Million | ▲ +144.7% |
| 2019 | 0.21x | NT$502.62 Million | NT$104.17 Million | ▼ -93.1% |
| 2018 | 3.02x | NT$33.91 Million | NT$102.27 Million | ▲ +6.4% |
| 2017 | 2.83x | NT$62.76 Million | NT$177.91 Million | — |